Such notion is supported by the fact that genetic depletion and pharmacological inhibition of ASK1 in vivo and in vitro increased hepatic lipid droplet accumulation and/or liver fibrosis, potentially via blocking autophagy function. Here, MAP3K5 is linked to Hepatic fibrosis.